Antimicrobial Optimisation Workshop

2 March 2018


On February 21 2018, CRE REDUCE delivered a successful workshop focused on the current and emerging strategies for optimisation of antimicrobial dosing in various patient populations.

Topics ranged from emerging antimicrobial resistance in Asia-Pacific to the role of bacterial genomics and proteomics in antimicrobial stewardship and optimisation of antimicrobial dosing.

Importantly, the work presented did not exclusively focus on antibiotics but also on the role antifungal stewardship in combating antimicrobial resistance. This work was presented by Karen Urbancic, our collaborator from NCAS.

International guests speakers included Prof Mark Wilcox (UK), Prof Yehuda Carmeli (Israel) and A/ Prof Natalie Schellack (South Africa).

Prof Yehuda Carmeli from Tel Aviv University, Israel & Harvard Medical School demonstrated that the future might not be as bleak as it is easy to imagine by outlining some of the new antibiotics in the pipeline.

A/Prof Natalie Schellack shared some wonderful (and well deserved) antimicrobial stewardship success stories from across South Africa despite the unique challenges they face as a developing nation. 

Domestic and local speakers included Prof David Paterson, Prof Jeffrey Lipman and Dr Kathryn Daveson - a superb mix of clinicians - researchers, scientists and academics.

There were 94 total attendees from 6 different states across Australia and 4 International locations.

The afternoon tutorial sessions were a huge success with delegates sharing a range of creative strategies to improve current antimicrobial stewardship programs and avoid antimicrobial stewardship “fatigue”.

Please access the videos of the presentations here.

We are very thankful to our sponsors Merck Sharp & Dohme (Australia) and Pfizer, without whom it would not have been possible to deliver the workshop.